Search

everythinglearnresearchcommunity

for

Search:↓

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Erdr1 could be a new marker for diagnosing hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Fractional laser therapy may help regrow hair in alopecia areata.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The document explains various skin conditions and their treatments.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

A dermoscope helps accurately tell apart Pityrosporum folliculitis and Acne vulgaris.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.